Why Tempus AI Stock Is Up Wednesday?
Tempus AI Inc (NASDAQ:TEM) shares are trading higher Wednesday morning after Needham analyst Ryan MacDonald reiterated a Buy rating on the stock and maintained a $75 price target.
The move also came after Tempus announced a newly published study in JCO Precision Oncology highlighting the value of advanced genomic profiling tools in identifying clinically actionable findings for cancer patients in community oncology settings. Here’s what investors need to know.
- Tempus AI stock is among today’s top performers. Why is TEM stock up today?
Tempus Study Highlights Benefits of Advanced Genomic Profiling
According to the company, the research was conducted in collaboration with The Oncology Institute and found that features such as tumor-normal matched sequencing, RNA sequencing and liquid biopsy reflex testing uncovered treatment-relevant findings that could be missed by more limited standard testing.
Tempus said about 12% of patients across the study's pilot and expanded cohorts had potentially actionable findings tied to an approved therapy that were identified solely through those advanced testing features.
Tempus AI Platform Strengthens Precision Medicine Investment Narrative
The company said the results underscore how more comprehensive genomic profiling can expand treatment options and improve access to targeted therapies and clinical trial opportunities.
The announcement adds to investor focus on Tempus' AI-driven precision medicine platform, as the company continues positioning its data and diagnostics capabilities as a differentiator in oncology and broader healthcare analytics.
Tempus AI Trades Below Key Moving Averages
Tempus AI shares were volatile over the past year, climbing from a low of $37.23 to a peak of $103.25 before pulling back sharply into March 2026.
The recent trend is weaker, with the stock trading below its 20-day, 50-day and 200-day moving averages, signaling continued downside pressure.
TEM Shares Edge Higher Wednesday Morning
TEM Price Action: Tempus AI shares were up 3.83% at $52.85 at the time of publication on Wednesday, according to Benzinga Pro data.
Image: Shutterstock